Laura Esparcia
Overview
Explore the profile of Laura Esparcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsukalov I, Sanchez-Cerrillo I, Rajas O, Avalos E, Iturricastillo G, Esparcia L, et al.
Nat Commun
. 2024 Mar;
15(1):2100.
PMID: 38453949
Increased recruitment of transitional and non-classical monocytes in the lung during SARS-CoV-2 infection is associated with COVID-19 severity. However, whether specific innate sensors mediate the activation or differentiation of monocytes...
2.
Rodriguez-Serrano D, Roy-Vallejo E, Zurita Cruz N, Martin Ramirez A, Rodriguez-Garcia S, Arevalillo-Fernandez N, et al.
Sci Rep
. 2021 Jun;
11(1):13134.
PMID: 34162948
COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as...
3.
Marcos-Jimenez A, Sanchez-Alonso S, Alcaraz-Serna A, Esparcia L, Lopez-Sanz C, Sampedro-Nunez M, et al.
Eur J Immunol
. 2020 Nov;
51(3):634-647.
PMID: 33251605
SARS-CoV-2 infection causes an abrupt response by the host immune system, which is largely responsible for the outcome of COVID-19. We investigated whether the specific immune responses in the peripheral...
4.
Galvan-Roman J, Rodriguez-Garcia S, Roy-Vallejo E, Marcos-Jimenez A, Sanchez-Alonso S, Fernandez-Diaz C, et al.
J Allergy Clin Immunol
. 2020 Oct;
147(1):72-80.e8.
PMID: 33010257
Background: Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine release syndrome that eventually leads to acute respiratory distress syndrome requiring invasive mechanical ventilation (IMV). Because IL-6 is a...
5.
Sanchez-Cerrillo I, Landete P, Aldave B, Sanchez-Alonso S, Sanchez-Azofra A, Marcos-Jimenez A, et al.
J Clin Invest
. 2020 Aug;
130(12):6290-6300.
PMID: 32784290
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in infected individuals, who can either exhibit mild symptoms or progress toward a life-threatening acute respiratory distress syndrome (ARDS)....
6.
Sanchez-Cerrillo I, Landete P, Aldave B, Sanchez-Alonso S, Sanchez-Azofra A, Marcos-Jimenez A, et al.
medRxiv
. 2020 Jun;
PMID: 32511573
The SARS-CoV-2 is responsible for the pandemic COVID-19 in infected individuals, who can either exhibit mild symptoms or progress towards a life-threatening acute respiratory distress syndrome (ARDS). It is known...